Blood, ISSN 0006-4971, 02/2013, Volume 121, Issue 9, pp. 1495 - 1500
Histiocytoses are rare disorders of unknown origin with highly heterogeneous prognosis. BRAF(V600E) gain-of-function mutations have been observed in 57% of...
HEMATOLOGY | MELANOMA | Erdheim-Chester Disease - genetics | Glutamic Acid - genetics | Histiocytosis, Langerhans-Cell - genetics | Humans | Middle Aged | Male | Treatment Outcome | Drug Resistance - drug effects | Erdheim-Chester Disease - pathology | Drug Resistance - genetics | Erdheim-Chester Disease - drug therapy | Mutation, Missense - physiology | Histiocytosis, Langerhans-Cell - pathology | Sulfonamides - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Anti-Inflammatory Agents - therapeutic use | Adult | Female | Indoles - therapeutic use | Valine - genetics | Aged | Amino Acid Substitution | Histiocytosis, Langerhans-Cell - drug therapy
HEMATOLOGY | MELANOMA | Erdheim-Chester Disease - genetics | Glutamic Acid - genetics | Histiocytosis, Langerhans-Cell - genetics | Humans | Middle Aged | Male | Treatment Outcome | Drug Resistance - drug effects | Erdheim-Chester Disease - pathology | Drug Resistance - genetics | Erdheim-Chester Disease - drug therapy | Mutation, Missense - physiology | Histiocytosis, Langerhans-Cell - pathology | Sulfonamides - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Anti-Inflammatory Agents - therapeutic use | Adult | Female | Indoles - therapeutic use | Valine - genetics | Aged | Amino Acid Substitution | Histiocytosis, Langerhans-Cell - drug therapy
Journal Article
Blood, ISSN 0006-4971, 07/2017, Volume 130, Issue 2, pp. 167 - 175
Langerhans cell histiocytosis (LCH) and Erdheim-Chester disease (ECD) are rare histiocytic disorders induced by somatic mutation of MAPK pathway genes....
MANAGEMENT | DENDRITIC CELLS | NEOPLASMS | DISTINCT | MONOCYTES | SUBSETS | NOTCH | MUTATIONS | MATURATION | HEMATOLOGY | BLOOD | Antigens, CD - immunology | Dendritic Cells - immunology | Histiocytosis, Langerhans-Cell - diagnosis | Histiocytosis, Langerhans-Cell - genetics | Humans | Lectins, C-Type - immunology | Dendritic Cells - pathology | Hematopoietic Stem Cells - pathology | Erdheim-Chester Disease - immunology | Male | Receptors, Notch - genetics | Monocytes - immunology | Lectins, C-Type - genetics | Antigens, CD - genetics | Hematopoietic Stem Cells - immunology | Histiocytosis, Langerhans-Cell - pathology | Bone Marrow Cells - immunology | Monocytes - pathology | Adult | Female | Cell Differentiation | Foam Cells - pathology | Glycoproteins - genetics | Transforming Growth Factor beta - immunology | Antigens, CD1 - immunology | Diagnosis, Differential | Erdheim-Chester Disease - genetics | Gene Expression | Bone Marrow Cells - pathology | Immunophenotyping | Lipopolysaccharide Receptors - immunology | Histiocytosis, Langerhans-Cell - immunology | Erdheim-Chester Disease - pathology | Granulocyte-Macrophage Colony-Stimulating Factor - genetics | Glycoproteins - immunology | Granulocyte-Macrophage Colony-Stimulating Factor - immunology | Mannose-Binding Lectins - genetics | Mannose-Binding Lectins - immunology | Transforming Growth Factor beta - genetics | Proto-Oncogene Proteins B-raf - genetics | Proto-Oncogene Proteins B-raf - immunology | Alleles | Erdheim-Chester Disease - diagnosis | Lipopolysaccharide Receptors - genetics | Foam Cells - immunology | Antigens, CD1 - genetics | Mutation | Receptors, Notch - immunology | Myeloid Neoplasia
MANAGEMENT | DENDRITIC CELLS | NEOPLASMS | DISTINCT | MONOCYTES | SUBSETS | NOTCH | MUTATIONS | MATURATION | HEMATOLOGY | BLOOD | Antigens, CD - immunology | Dendritic Cells - immunology | Histiocytosis, Langerhans-Cell - diagnosis | Histiocytosis, Langerhans-Cell - genetics | Humans | Lectins, C-Type - immunology | Dendritic Cells - pathology | Hematopoietic Stem Cells - pathology | Erdheim-Chester Disease - immunology | Male | Receptors, Notch - genetics | Monocytes - immunology | Lectins, C-Type - genetics | Antigens, CD - genetics | Hematopoietic Stem Cells - immunology | Histiocytosis, Langerhans-Cell - pathology | Bone Marrow Cells - immunology | Monocytes - pathology | Adult | Female | Cell Differentiation | Foam Cells - pathology | Glycoproteins - genetics | Transforming Growth Factor beta - immunology | Antigens, CD1 - immunology | Diagnosis, Differential | Erdheim-Chester Disease - genetics | Gene Expression | Bone Marrow Cells - pathology | Immunophenotyping | Lipopolysaccharide Receptors - immunology | Histiocytosis, Langerhans-Cell - immunology | Erdheim-Chester Disease - pathology | Granulocyte-Macrophage Colony-Stimulating Factor - genetics | Glycoproteins - immunology | Granulocyte-Macrophage Colony-Stimulating Factor - immunology | Mannose-Binding Lectins - genetics | Mannose-Binding Lectins - immunology | Transforming Growth Factor beta - genetics | Proto-Oncogene Proteins B-raf - genetics | Proto-Oncogene Proteins B-raf - immunology | Alleles | Erdheim-Chester Disease - diagnosis | Lipopolysaccharide Receptors - genetics | Foam Cells - immunology | Antigens, CD1 - genetics | Mutation | Receptors, Notch - immunology | Myeloid Neoplasia
Journal Article
Critical Reviews in Oncology and Hematology, ISSN 1040-8428, 2015, Volume 95, Issue 1, pp. 1 - 11
Highlights • CNS involvement occurs in 56% of ECD patients. • Concomitant pituitary involvement, retro-orbital and axial lesions suggest ECD diagnosis. •...
Hematology, Oncology and Palliative Medicine | Vemurafenib | BRAFV600E | CNS involvement | Histiocytosis | Erdheim–Chester disease | BRAF V600E | Erdheim-Chester disease | INVOLVEMENT | BRAF V600E MUTATION | BRAF(V600E) | IRRADIATION | ONCOLOGY | LANGERHANS CELL HISTIOCYTOSIS | PITUITARY | CENTRAL-NERVOUS-SYSTEM | SENESCENCE | LEUKEMIA | OF-THE-LITERATURE | HEMATOLOGY | MANIFESTATIONS | Bone and Bones - pathology | Erdheim-Chester Disease - genetics | Prognosis | Kidney - pathology | Humans | Central Nervous System - pathology | Male | Myocardium - pathology | Adrenal Cortex Hormones - therapeutic use | Erdheim-Chester Disease - pathology | Point Mutation | Erdheim-Chester Disease - drug therapy | Proto-Oncogene Proteins B-raf - genetics | Erdheim-Chester Disease - diagnosis | Adult
Hematology, Oncology and Palliative Medicine | Vemurafenib | BRAFV600E | CNS involvement | Histiocytosis | Erdheim–Chester disease | BRAF V600E | Erdheim-Chester disease | INVOLVEMENT | BRAF V600E MUTATION | BRAF(V600E) | IRRADIATION | ONCOLOGY | LANGERHANS CELL HISTIOCYTOSIS | PITUITARY | CENTRAL-NERVOUS-SYSTEM | SENESCENCE | LEUKEMIA | OF-THE-LITERATURE | HEMATOLOGY | MANIFESTATIONS | Bone and Bones - pathology | Erdheim-Chester Disease - genetics | Prognosis | Kidney - pathology | Humans | Central Nervous System - pathology | Male | Myocardium - pathology | Adrenal Cortex Hormones - therapeutic use | Erdheim-Chester Disease - pathology | Point Mutation | Erdheim-Chester Disease - drug therapy | Proto-Oncogene Proteins B-raf - genetics | Erdheim-Chester Disease - diagnosis | Adult
Journal Article
Nature, ISSN 0028-0836, 09/2017, Volume 549, Issue 7672, pp. 389 - 393
The pathophysiology of neurodegenerative diseases is poorly understood and there are few therapeutic options. Neurodegenerative diseases are characterized by...
DENDRITIC CELLS | PATTERN | LANGERHANS CELL HISTIOCYTOSIS | ALZHEIMERS-DISEASE | MULTIDISCIPLINARY SCIENCES | KINASE | MICE | MODEL | ERDHEIM-CHESTER-DISEASE | EXPRESSION | Microglia - metabolism | Clone Cells - enzymology | Humans | Male | Myeloid Progenitor Cells - enzymology | Extracellular Signal-Regulated MAP Kinases - metabolism | MAP Kinase Signaling System | Erythroid Precursor Cells - enzymology | Histiocytosis - pathology | Microglia - pathology | Female | Proto-Oncogene Proteins B-raf - metabolism | Disease Models, Animal | Histiocytosis - enzymology | Myeloid Progenitor Cells - metabolism | Neurodegenerative Diseases - pathology | Macrophages - pathology | Microglia - enzymology | Neurodegenerative Diseases - genetics | Myeloid Progenitor Cells - pathology | Histiocytosis - metabolism | Neurodegenerative Diseases - metabolism | Clone Cells - metabolism | Macrophages - enzymology | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Erythroid Precursor Cells - pathology | Macrophages - metabolism | Animals | Clone Cells - pathology | Proto-Oncogene Proteins B-raf - genetics | Histiocytosis - genetics | Erythroid Precursor Cells - metabolism | Mosaicism | Mice | Mutation | Neurodegenerative Diseases - enzymology | Physiological aspects | Nervous system | Development and progression | Degeneration | Genetic aspects | Research | Histiocytosis | Mitogen-activated protein kinases | Intervention | Disease | Stem cell transplantation | Activation | Genomes | Kinases | Macrophages | Neuronal-glial interactions | Genotype & phenotype | Allografts | Neurodegeneration | Rodents | Bone marrow | Ataxia | Alzheimer's disease | Myeloid cells | Cytokines | Neurodegenerative diseases | Fetuses | Extracellular signal-regulated kinase | MAP kinase | Cell lineage | Gene expression | Patients | Amyloid precursor protein | Microglia | Organogenesis | Diseases | Neurological diseases | Gliosis | Stem cells | Neural stem cells
DENDRITIC CELLS | PATTERN | LANGERHANS CELL HISTIOCYTOSIS | ALZHEIMERS-DISEASE | MULTIDISCIPLINARY SCIENCES | KINASE | MICE | MODEL | ERDHEIM-CHESTER-DISEASE | EXPRESSION | Microglia - metabolism | Clone Cells - enzymology | Humans | Male | Myeloid Progenitor Cells - enzymology | Extracellular Signal-Regulated MAP Kinases - metabolism | MAP Kinase Signaling System | Erythroid Precursor Cells - enzymology | Histiocytosis - pathology | Microglia - pathology | Female | Proto-Oncogene Proteins B-raf - metabolism | Disease Models, Animal | Histiocytosis - enzymology | Myeloid Progenitor Cells - metabolism | Neurodegenerative Diseases - pathology | Macrophages - pathology | Microglia - enzymology | Neurodegenerative Diseases - genetics | Myeloid Progenitor Cells - pathology | Histiocytosis - metabolism | Neurodegenerative Diseases - metabolism | Clone Cells - metabolism | Macrophages - enzymology | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Erythroid Precursor Cells - pathology | Macrophages - metabolism | Animals | Clone Cells - pathology | Proto-Oncogene Proteins B-raf - genetics | Histiocytosis - genetics | Erythroid Precursor Cells - metabolism | Mosaicism | Mice | Mutation | Neurodegenerative Diseases - enzymology | Physiological aspects | Nervous system | Development and progression | Degeneration | Genetic aspects | Research | Histiocytosis | Mitogen-activated protein kinases | Intervention | Disease | Stem cell transplantation | Activation | Genomes | Kinases | Macrophages | Neuronal-glial interactions | Genotype & phenotype | Allografts | Neurodegeneration | Rodents | Bone marrow | Ataxia | Alzheimer's disease | Myeloid cells | Cytokines | Neurodegenerative diseases | Fetuses | Extracellular signal-regulated kinase | MAP kinase | Cell lineage | Gene expression | Patients | Amyloid precursor protein | Microglia | Organogenesis | Diseases | Neurological diseases | Gliosis | Stem cells | Neural stem cells
Journal Article
Modern Pathology, ISSN 0893-3952, 04/2018, Volume 31, Issue 4, pp. 581 - 597
Erdheim-Chester disease is a rare, non-Langerhans cell histiocytosis histologically characterized by multi-systemic proliferation of mature histiocytes in a...
KINASE ALTERATIONS | MUTATIONS | PATHOLOGY | Erdheim-Chester Disease - genetics | Humans | Erdheim-Chester Disease - pathology | Cohort Studies | Retroperitoneum | Oral cavity | Biopsy | Stroma | Bone marrow | Mutation | Histiocytosis | Heart diseases
KINASE ALTERATIONS | MUTATIONS | PATHOLOGY | Erdheim-Chester Disease - genetics | Humans | Erdheim-Chester Disease - pathology | Cohort Studies | Retroperitoneum | Oral cavity | Biopsy | Stroma | Bone marrow | Mutation | Histiocytosis | Heart diseases
Journal Article
Blood, ISSN 0006-4971, 03/2011, Volume 117, Issue 10, pp. 2778 - 2782
Erdheim-Chester disease (ECD) is a rare form of non-Langerhans histiocytosis, with noncodified therapeutic management and high mortality. No treatment has yet...
MAGNETIC-RESONANCE | HEMATOLOGY | RECEPTOR | Prognosis | Follow-Up Studies | Humans | Middle Aged | Interferon-alpha - therapeutic use | Kaplan-Meier Estimate | Proportional Hazards Models | Male | Erdheim-Chester Disease - pathology | Young Adult | Erdheim-Chester Disease - drug therapy | Adolescent | Aged, 80 and over | Brain - pathology | Adult | Female | Aged | Erdheim-Chester Disease - mortality | Child | Cohort Studies | Immunologic Factors - therapeutic use
MAGNETIC-RESONANCE | HEMATOLOGY | RECEPTOR | Prognosis | Follow-Up Studies | Humans | Middle Aged | Interferon-alpha - therapeutic use | Kaplan-Meier Estimate | Proportional Hazards Models | Male | Erdheim-Chester Disease - pathology | Young Adult | Erdheim-Chester Disease - drug therapy | Adolescent | Aged, 80 and over | Brain - pathology | Adult | Female | Aged | Erdheim-Chester Disease - mortality | Child | Cohort Studies | Immunologic Factors - therapeutic use
Journal Article
Blood, ISSN 0006-4971, 08/2014, Volume 124, Issue 7, pp. 1119 - 1126
Histiocytoses are a group of heterogeneous diseases that mostly comprise Langerhans cell histiocytosis (LCH) and non-LCH. The association of LCH with non-LCH...
Erdheim-Chester Disease - genetics | Genetic Predisposition to Disease - genetics | Histiocytosis, Langerhans-Cell - genetics | Humans | Middle Aged | Kaplan-Meier Estimate | Child, Preschool | Male | Treatment Outcome | Mutation, Missense | Erdheim-Chester Disease - pathology | Young Adult | Erdheim-Chester Disease - drug therapy | Histiocytosis, Langerhans-Cell - pathology | DNA Mutational Analysis | Proto-Oncogene Proteins B-raf - genetics | Adolescent | Adult | Female | Aged | Child | Histiocytosis, Langerhans-Cell - drug therapy | Life Sciences
Erdheim-Chester Disease - genetics | Genetic Predisposition to Disease - genetics | Histiocytosis, Langerhans-Cell - genetics | Humans | Middle Aged | Kaplan-Meier Estimate | Child, Preschool | Male | Treatment Outcome | Mutation, Missense | Erdheim-Chester Disease - pathology | Young Adult | Erdheim-Chester Disease - drug therapy | Histiocytosis, Langerhans-Cell - pathology | DNA Mutational Analysis | Proto-Oncogene Proteins B-raf - genetics | Adolescent | Adult | Female | Aged | Child | Histiocytosis, Langerhans-Cell - drug therapy | Life Sciences
Journal Article
Cardiology Clinics, ISSN 0733-8651, 11/2017, Volume 35, Issue 4, pp. 589 - 600
Pericardial tumors are rare lesions that include a range of neoplastic conditions that may arise within the pericardium or metastasize to involve it...
Masses | Epicardium | Thoracic | Cardiac | Tumors | IGG4-RELATED DISEASE | CARDIAC & CARDIOVASCULAR SYSTEMS | CARDIAC ANGIOSARCOMA | IMAGING FINDINGS | RADIOLOGIC-PATHOLOGICAL CORRELATION | ERDHEIM-CHESTER DISEASE | MAGNETIC-RESONANCE | EPICARDIAL LIPOMA | OF-THE-LITERATURE | CONSTRICTIVE PERICARDITIS | Heart Neoplasms - pathology | Hemangioma - pathology | Mesothelioma - pathology | Hemangioma - diagnostic imaging | Humans | Heart Neoplasms - diagnostic imaging | Tomography, X-Ray Computed | Carcinoma - diagnostic imaging | Erdheim-Chester Disease - therapy | Mediastinal Cyst - therapy | Pericardium - diagnostic imaging | Lipoma - therapy | Hemangiosarcoma - therapy | Mesothelioma - therapy | Echocardiography | Paraganglioma - therapy | Lung Neoplasms - therapy | Sarcoma - pathology | Erdheim-Chester Disease - pathology | Magnetic Resonance Imaging | Mesothelioma - diagnostic imaging | Mediastinal Cyst - pathology | Lung Neoplasms - diagnostic imaging | Sarcoma - diagnostic imaging | Hemangiosarcoma - diagnostic imaging | Neoplasms, Germ Cell and Embryonal - therapy | Erdheim-Chester Disease - diagnostic imaging | Lymphoma - diagnostic imaging | Immunoglobulin G | Lung Neoplasms - pathology | Lipoma - pathology | Sarcoma - therapy | Hemangioma - therapy | Lymphoma - therapy | Pericardium - pathology | Lymphoma - pathology | Mediastinal Cyst - diagnostic imaging | Carcinoma - secondary | Sarcoma, Synovial - diagnostic imaging | Hemangiosarcoma - pathology | Paraganglioma - pathology | Sarcoma, Synovial - therapy | Heart Neoplasms - therapy | Neoplasms, Germ Cell and Embryonal - diagnostic imaging | Paraganglioma - diagnostic imaging | Breast Neoplasms - pathology | Heart Neoplasms - secondary | Autoimmune Diseases | Carcinoma - therapy | Lipoma - diagnostic imaging | Radiography, Thoracic | Sarcoma, Synovial - pathology | Neoplasms, Germ Cell and Embryonal - pathology
Masses | Epicardium | Thoracic | Cardiac | Tumors | IGG4-RELATED DISEASE | CARDIAC & CARDIOVASCULAR SYSTEMS | CARDIAC ANGIOSARCOMA | IMAGING FINDINGS | RADIOLOGIC-PATHOLOGICAL CORRELATION | ERDHEIM-CHESTER DISEASE | MAGNETIC-RESONANCE | EPICARDIAL LIPOMA | OF-THE-LITERATURE | CONSTRICTIVE PERICARDITIS | Heart Neoplasms - pathology | Hemangioma - pathology | Mesothelioma - pathology | Hemangioma - diagnostic imaging | Humans | Heart Neoplasms - diagnostic imaging | Tomography, X-Ray Computed | Carcinoma - diagnostic imaging | Erdheim-Chester Disease - therapy | Mediastinal Cyst - therapy | Pericardium - diagnostic imaging | Lipoma - therapy | Hemangiosarcoma - therapy | Mesothelioma - therapy | Echocardiography | Paraganglioma - therapy | Lung Neoplasms - therapy | Sarcoma - pathology | Erdheim-Chester Disease - pathology | Magnetic Resonance Imaging | Mesothelioma - diagnostic imaging | Mediastinal Cyst - pathology | Lung Neoplasms - diagnostic imaging | Sarcoma - diagnostic imaging | Hemangiosarcoma - diagnostic imaging | Neoplasms, Germ Cell and Embryonal - therapy | Erdheim-Chester Disease - diagnostic imaging | Lymphoma - diagnostic imaging | Immunoglobulin G | Lung Neoplasms - pathology | Lipoma - pathology | Sarcoma - therapy | Hemangioma - therapy | Lymphoma - therapy | Pericardium - pathology | Lymphoma - pathology | Mediastinal Cyst - diagnostic imaging | Carcinoma - secondary | Sarcoma, Synovial - diagnostic imaging | Hemangiosarcoma - pathology | Paraganglioma - pathology | Sarcoma, Synovial - therapy | Heart Neoplasms - therapy | Neoplasms, Germ Cell and Embryonal - diagnostic imaging | Paraganglioma - diagnostic imaging | Breast Neoplasms - pathology | Heart Neoplasms - secondary | Autoimmune Diseases | Carcinoma - therapy | Lipoma - diagnostic imaging | Radiography, Thoracic | Sarcoma, Synovial - pathology | Neoplasms, Germ Cell and Embryonal - pathology
Journal Article
Blood, ISSN 0006-4971, 07/2017, Volume 130, Issue 2, pp. 176 - 180
Langerhans cell histiocytosis (LCH) and the non-LCH neoplasm Erdheim-Chester disease (ECD) are heterogeneous neoplastic disorders marked by infiltration of...
PATHOGENESIS | ERDHEIM-CHESTER DISEASE | MAP2K1 | ACTIVATION | DENDRITIC CELLS | EFFICACY | MUTATIONS | HEMATOLOGY | HIGH PREVALENCE | EXPRESSION | VEMURAFENIB | Dendritic Cells - immunology | Histiocytosis, Langerhans-Cell - genetics | Humans | Dendritic Cells - pathology | Hematopoietic Stem Cells - pathology | Erdheim-Chester Disease - immunology | Transplantation, Heterologous | Monocytes - immunology | Hematopoietic Stem Cells - immunology | Antigens, CD34 - immunology | Histiocytosis, Langerhans-Cell - pathology | Bone Marrow Cells - immunology | Bone Marrow Transplantation | Monocytes - pathology | Proto-Oncogene Proteins - immunology | Adult | Cell Differentiation | Macrophages - immunology | Erdheim-Chester Disease - genetics | Gene Expression | DNA-Binding Proteins - immunology | Macrophages - pathology | Bone Marrow Cells - pathology | Immunophenotyping | Proto-Oncogene Proteins - genetics | DNA-Binding Proteins - genetics | Histiocytosis, Langerhans-Cell - immunology | Erdheim-Chester Disease - pathology | Animals | Proto-Oncogene Proteins B-raf - genetics | Proto-Oncogene Proteins B-raf - immunology | Alleles | Mice | Mutation | Antigens, CD34 - genetics | Life Sciences | Biochemistry, Molecular Biology | Cancer | Brief Report | Myeloid Neoplasia
PATHOGENESIS | ERDHEIM-CHESTER DISEASE | MAP2K1 | ACTIVATION | DENDRITIC CELLS | EFFICACY | MUTATIONS | HEMATOLOGY | HIGH PREVALENCE | EXPRESSION | VEMURAFENIB | Dendritic Cells - immunology | Histiocytosis, Langerhans-Cell - genetics | Humans | Dendritic Cells - pathology | Hematopoietic Stem Cells - pathology | Erdheim-Chester Disease - immunology | Transplantation, Heterologous | Monocytes - immunology | Hematopoietic Stem Cells - immunology | Antigens, CD34 - immunology | Histiocytosis, Langerhans-Cell - pathology | Bone Marrow Cells - immunology | Bone Marrow Transplantation | Monocytes - pathology | Proto-Oncogene Proteins - immunology | Adult | Cell Differentiation | Macrophages - immunology | Erdheim-Chester Disease - genetics | Gene Expression | DNA-Binding Proteins - immunology | Macrophages - pathology | Bone Marrow Cells - pathology | Immunophenotyping | Proto-Oncogene Proteins - genetics | DNA-Binding Proteins - genetics | Histiocytosis, Langerhans-Cell - immunology | Erdheim-Chester Disease - pathology | Animals | Proto-Oncogene Proteins B-raf - genetics | Proto-Oncogene Proteins B-raf - immunology | Alleles | Mice | Mutation | Antigens, CD34 - genetics | Life Sciences | Biochemistry, Molecular Biology | Cancer | Brief Report | Myeloid Neoplasia
Journal Article
American Journal of Surgical Pathology, ISSN 0147-5185, 10/2009, Volume 33, Issue 10, pp. 1450 - 1462
Autoimmune pancreatitis (AP) is one manifestation of a systemic, steroid-responsive disease with elevated serum IgG4 and characteristic histopathology,...
Rosai-Dorfman disease | Inflammatory and interstitial lung disease | IgG4 | Erdheim-Chester disease | Autoimmune pancreatitis | Sjögren syndrome | Inflammatory myofibroblastic tumor | FIBROSIS | SURGERY | LUNG | inflammatory and interstitial lung disease | inflammatory myofibroblastic tumor | INVOLVEMENT | INTERSTITIAL PNEUMONIA | autoimmune pancreatitis | PATHOLOGY | CLINICOPATHOLOGICAL ENTITY | INFILTRATION | INFLAMMATORY PSEUDOTUMORS | IGG4-RELATED SCLEROSING DISEASE | SERUM IGG4 LEVEL | Sjogren syndrome | ORGANIZING PNEUMONIA | Histiocytosis, Sinus - pathology | Immunohistochemistry | Lung Diseases, Interstitial - etiology | Immunoglobulin G - blood | Lung Diseases, Interstitial - pathology | Humans | Middle Aged | Autoimmune Diseases - complications | Autoimmune Diseases - immunology | Male | Pancreatitis - complications | Lung Diseases, Interstitial - immunology | Histiocytosis, Sinus - immunology | Immunoglobulin G - immunology | Aged, 80 and over | Pancreatitis - immunology | Female | Pancreatitis - pathology | Aged | Autoimmune Diseases - pathology | Plasma Cells - immunology
Rosai-Dorfman disease | Inflammatory and interstitial lung disease | IgG4 | Erdheim-Chester disease | Autoimmune pancreatitis | Sjögren syndrome | Inflammatory myofibroblastic tumor | FIBROSIS | SURGERY | LUNG | inflammatory and interstitial lung disease | inflammatory myofibroblastic tumor | INVOLVEMENT | INTERSTITIAL PNEUMONIA | autoimmune pancreatitis | PATHOLOGY | CLINICOPATHOLOGICAL ENTITY | INFILTRATION | INFLAMMATORY PSEUDOTUMORS | IGG4-RELATED SCLEROSING DISEASE | SERUM IGG4 LEVEL | Sjogren syndrome | ORGANIZING PNEUMONIA | Histiocytosis, Sinus - pathology | Immunohistochemistry | Lung Diseases, Interstitial - etiology | Immunoglobulin G - blood | Lung Diseases, Interstitial - pathology | Humans | Middle Aged | Autoimmune Diseases - complications | Autoimmune Diseases - immunology | Male | Pancreatitis - complications | Lung Diseases, Interstitial - immunology | Histiocytosis, Sinus - immunology | Immunoglobulin G - immunology | Aged, 80 and over | Pancreatitis - immunology | Female | Pancreatitis - pathology | Aged | Autoimmune Diseases - pathology | Plasma Cells - immunology
Journal Article
Human Pathology, ISSN 0046-8177, 2013, Volume 44, Issue 5, pp. 683 - 696
Summary The morphologic diagnosis of histiocytic lesions of the gastrointestinal tract can be challenging, and several disorders have to be considered in their...
Pathology | Xanthomatosis | Xanthogranulomatous inflammation | Langerhans cell histiocytosis | Malacoplakia | Melanosis coli | Rosai-Dorfman disease | Erdheim-Chester disease | Whipple disease | ROSAI-DORFMAN-DISEASE | MASSIVE LYMPHADENOPATHY | PATHOLOGY | HERMANSKY-PUDLAK-SYNDROME | SINUS HISTIOCYTOSIS | PARAFFIN-EMBEDDED TISSUE | ERDHEIM-CHESTER-DISEASE | OF-THE-LITERATURE | MELANOSIS-COLI | Histiocytosis, Sinus - pathology | Immunohistochemistry | Malacoplakia - pathology | Diagnosis, Differential | Humans | Child, Preschool | Histiocytes - pathology | Male | Xanthomatosis - complications | Xanthogranuloma, Juvenile - pathology | Erdheim-Chester Disease - pathology | Gastrointestinal Tract - pathology | Lysosomal Storage Diseases - pathology | Xanthomatosis - pathology | Young Adult | Histiocytosis, Langerhans-Cell - pathology | Gastrointestinal Diseases - pathology | Histiocytosis - pathology | Whipple Disease - pathology | Adult | Tangier Disease - pathology | Gastrointestinal system | Proteins | Postoperative period | Disease | Antibiotics | Lipids | Growth hormones | Chromosomes | Age | Cholesterol
Pathology | Xanthomatosis | Xanthogranulomatous inflammation | Langerhans cell histiocytosis | Malacoplakia | Melanosis coli | Rosai-Dorfman disease | Erdheim-Chester disease | Whipple disease | ROSAI-DORFMAN-DISEASE | MASSIVE LYMPHADENOPATHY | PATHOLOGY | HERMANSKY-PUDLAK-SYNDROME | SINUS HISTIOCYTOSIS | PARAFFIN-EMBEDDED TISSUE | ERDHEIM-CHESTER-DISEASE | OF-THE-LITERATURE | MELANOSIS-COLI | Histiocytosis, Sinus - pathology | Immunohistochemistry | Malacoplakia - pathology | Diagnosis, Differential | Humans | Child, Preschool | Histiocytes - pathology | Male | Xanthomatosis - complications | Xanthogranuloma, Juvenile - pathology | Erdheim-Chester Disease - pathology | Gastrointestinal Tract - pathology | Lysosomal Storage Diseases - pathology | Xanthomatosis - pathology | Young Adult | Histiocytosis, Langerhans-Cell - pathology | Gastrointestinal Diseases - pathology | Histiocytosis - pathology | Whipple Disease - pathology | Adult | Tangier Disease - pathology | Gastrointestinal system | Proteins | Postoperative period | Disease | Antibiotics | Lipids | Growth hormones | Chromosomes | Age | Cholesterol
Journal Article
Current Opinion in Rheumatology, ISSN 1040-8711, 01/2012, Volume 24, Issue 1, pp. 53 - 59
PURPOSE OF REVIEWErdheim–Chester disease (ECD) is a rare, non-Langerhans form of histiocytosis first described in 1930 with a wide range of manifestations. The...
cytokine | DIAGNOSIS | IMAGING FINDINGS | ORBITAL INVOLVEMENT | RHEUMATOLOGY | histiocytosis | CHEMOTHERAPY | TRANSPLANTATION | INTERFERON-ALPHA | Langerhans-cell histiocytosis | Erdheim-Chester disease | interferon alpha | OF-THE-LITERATURE | IMATINIB MESYLATE | MANIFESTATIONS | Radiography | Erdheim-Chester Disease - drug therapy | Erdheim-Chester Disease - diagnostic imaging | Prognosis | Humans | Interferon-alpha - therapeutic use | Erdheim-Chester Disease - pathology | Histiocytosis | Cytokine | Interferon alpha
cytokine | DIAGNOSIS | IMAGING FINDINGS | ORBITAL INVOLVEMENT | RHEUMATOLOGY | histiocytosis | CHEMOTHERAPY | TRANSPLANTATION | INTERFERON-ALPHA | Langerhans-cell histiocytosis | Erdheim-Chester disease | interferon alpha | OF-THE-LITERATURE | IMATINIB MESYLATE | MANIFESTATIONS | Radiography | Erdheim-Chester Disease - drug therapy | Erdheim-Chester Disease - diagnostic imaging | Prognosis | Humans | Interferon-alpha - therapeutic use | Erdheim-Chester Disease - pathology | Histiocytosis | Cytokine | Interferon alpha
Journal Article
Journal of Neuropathology & Experimental Neurology, ISSN 0022-3069, 12/2017, Volume 76, Issue 12, pp. 986 - 996
Abstract Erdheim–Chester disease (ECD) is a rare nonLangerhans cell histiocytosis. Although approximately 50% of cases eventually involve the central nervous...
Erdheim-Chester disease | NonLangerhans cell histiocytosis | Langerhans cell histiocytosis | Central nervous system | Rosai-Dorfman disease | MANIFESTATION | EFFICACY | BRAF V600E MUTATION | PATHOLOGY | NEUROSCIENCES | CLINICAL NEUROLOGY | THERAPY | VEMURAFENIB | Histiocytosis, Non-Langerhans-Cell - pathology | Diagnosis, Differential | Erdheim-Chester Disease - diagnostic imaging | Humans | Middle Aged | Fatal Outcome | Histiocytosis, Non-Langerhans-Cell - diagnostic imaging | Female | Male | Aged | Erdheim-Chester Disease - pathology | Biopsy
Erdheim-Chester disease | NonLangerhans cell histiocytosis | Langerhans cell histiocytosis | Central nervous system | Rosai-Dorfman disease | MANIFESTATION | EFFICACY | BRAF V600E MUTATION | PATHOLOGY | NEUROSCIENCES | CLINICAL NEUROLOGY | THERAPY | VEMURAFENIB | Histiocytosis, Non-Langerhans-Cell - pathology | Diagnosis, Differential | Erdheim-Chester Disease - diagnostic imaging | Humans | Middle Aged | Fatal Outcome | Histiocytosis, Non-Langerhans-Cell - diagnostic imaging | Female | Male | Aged | Erdheim-Chester Disease - pathology | Biopsy
Journal Article